MERCK CAPITAL VENTURES
Merck Capital Ventures invests in companies in various stages of development from the first round of institutional funding to later stage expansion opportunities. The firm does not invest in research based pharmaceutical, vaccine, and biotechnology companies. It seeks to invest in private Internet, commercialization, distribution and delivery of pharmaceuticals, and health care services. The firm typically invests in companies based in the United States and also considers non-United States compa... nies with significant United States operations. It typically invests between $3 million and $8 million. The firm seeks to co-invest and prefers a board representation in its portfolio companies. It also seeks to provide follow-on financing. Merck Capital Ventures, LLC was founded in November 2000 and is based in Woodcliff Lake, New Jersey. Merck Capital Ventures, LLC operates as an investment arm of Merck & Co. Inc.
MERCK CAPITAL VENTURES
Industry:
Biotechnology Finance Venture Capital
Founded:
2000-01-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Nginx Sitelinks Search Box Yoast WordPress SEO Plugin JsDelivr
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-10-25 | She's Well | Merck Capital Ventures investment in Seed Round - She's Well | 2.1 M USD |
| 2018-08-10 | Artios Pharma | Merck Capital Ventures investment in Series B - Artios Pharma | 65 M GBP |
| 2015-06-08 | Spero Therapeutics | Merck Capital Ventures investment in Series A - Spero Therapeutics | 30 M USD |
| 2012-01-16 | mihealth | Merck Capital Ventures investment in Venture Round - mihealth | N/A |
| 2011-07-13 | HTG Molecular Diagnostics | Merck Capital Ventures investment in Series D - HTG Molecular Diagnostics | 16.2 M USD |
| 2010-01-11 | ImpactRx | Merck Capital Ventures investment in Series E - ImpactRx | 1.2 M USD |
| 2008-11-28 | HTG Molecular Diagnostics | Merck Capital Ventures investment in Series C - HTG Molecular Diagnostics | 2.8 M USD |
| 2008-08-04 | PHT Corporation | Merck Capital Ventures investment in Series F - PHT Corporation | 1.03 M USD |
| 2008-04-21 | VisEn Medical | Merck Capital Ventures investment in Series B - VisEn Medical | 5 M USD |
| 2007-10-08 | HTG Molecular Diagnostics | Merck Capital Ventures investment in Series C - HTG Molecular Diagnostics | 5.62 M USD |